Liver Grafts Contain a Large Number of CD52 Negative Natural Killer Cells: Role for Infections after Liver Transplantation with Alemtuzumab Induction

Authors :: C Ricordi
Masahiro Ohira
Panagiotis Tryphonopoulos
Deborah Weppler
Philip Ruiz
G. Selvaggi
T. Dohi
E. Linetsky
Aisha Khan
A. G. Tzakis
Hideki Ohdan
Seigo Nishida
T. Matsuura
K. Uchida
D. M. Levi
Akin Tekin
Taizo Hibi
Ji Fan
Source :: Transplantation Journal. 94:229
Publication Year :: 2012
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2012.

Subjects :: Transplantation
Pathology
medicine.medical_specialty
CD52
business.industry
medicine.medical_treatment
Immunology
medicine
Alemtuzumab
Liver transplantation
business
medicine.drug

Full Text Access

Tools